EP
AVLN icon

Essential Partners’s Avalyn Pharma AVLN Stock Holding History

Essential Partners’s Portfolio AVLN Stock Details AVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$28 Buy
+1
New +$32 ﹤0.01% 2809

Other funds holding AVLN

AP
Andera Partners Paris $176M AUM 1.8% 1-Year Est. Return
LAM
Lewis Asset Management Lafayette, California $294M AUM 25.62% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Essential Partners's AVLN Position: Q3 2026 in Review

Essential Partners opened a new position in Avalyn Pharma (AVLN) in Q3 2026: 1 share worth $28. The stake represents ﹤0.01% of the portfolio and ranks #2809 among its holdings.

5 funds tracked by Wall St. Rank hold AVLN as of Q3 2026.

  • Essential Partners held 1 share of Avalyn Pharma worth $28 as of Q3 2026.
  • Avalyn Pharma was a new Essential Partners position in Q3 2026.
  • Avalyn Pharma made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #2809 holding.
  • 5 funds tracked by Wall St. Rank held Avalyn Pharma as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.